DrugPatentWatch Database Preview
Epinephrine; lidocaine hydrochloride - Generic Drug Details
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What are the generic sources for epinephrine; lidocaine hydrochloride and what is the scope of patent protection?
Epinephrine; lidocaine hydrochloride
is the generic ingredient in nine branded drugs marketed by Carlisle, Belmora Llc, Eastman Kodak, Hospira, West-ward Pharms Int, Abbott, Bel Mar, Dell Labs, Intl Medication, Watson Labs, Pharmaton, Septodont, Dentsply Pharm, Astrazeneca, Fresenius Kabi Usa, Vyteris, Iomed, and Empi, and is included in thirty-one NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.Epinephrine; lidocaine hydrochloride has eight patent family members in seven countries.
There are twenty-one drug master file entries for epinephrine; lidocaine hydrochloride. Ten suppliers are listed for this compound.
Summary for epinephrine; lidocaine hydrochloride
International Patents: | 8 |
US Patents: | 2 |
Tradenames: | 9 |
Applicants: | 18 |
NDAs: | 31 |
Drug Master File Entries: | 21 |
Suppliers / Packagers: | 10 |
Clinical Trials: | 142 |
DailyMed Link: | epinephrine; lidocaine hydrochloride at DailyMed |
Recent Clinical Trials for epinephrine; lidocaine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Missouri-Columbia | Early Phase 1 |
Geisinger Clinic | Phase 4 |
McGill University Health Center | N/A |
See all epinephrine; lidocaine hydrochloride clinical trials
Pharmacology for epinephrine; lidocaine hydrochloride
Drug Class | Amide Local Anesthetic Antiarrhythmic alpha-Adrenergic Agonist beta-Adrenergic Agonist Catecholamine |
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
Physiological Effect | Local Anesthesia |
US Patents and Regulatory Information for epinephrine; lidocaine hydrochloride
Expired US Patents for epinephrine; lidocaine hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Vyteris | LIDOSITE TOPICAL SYSTEM KIT | epinephrine; lidocaine hydrochloride | PATCH;IONTOPHORESIS, TOPICAL | 021504-001 | May 6, 2004 | Start Trial | Start Trial |
Vyteris | LIDOSITE TOPICAL SYSTEM KIT | epinephrine; lidocaine hydrochloride | PATCH;IONTOPHORESIS, TOPICAL | 021504-001 | May 6, 2004 | Start Trial | Start Trial |
Vyteris | LIDOSITE TOPICAL SYSTEM KIT | epinephrine; lidocaine hydrochloride | PATCH;IONTOPHORESIS, TOPICAL | 021504-001 | May 6, 2004 | Start Trial | Start Trial |
Vyteris | LIDOSITE TOPICAL SYSTEM KIT | epinephrine; lidocaine hydrochloride | PATCH;IONTOPHORESIS, TOPICAL | 021504-001 | May 6, 2004 | Start Trial | Start Trial |
Vyteris | LIDOSITE TOPICAL SYSTEM KIT | epinephrine; lidocaine hydrochloride | PATCH;IONTOPHORESIS, TOPICAL | 021504-001 | May 6, 2004 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for epinephrine; lidocaine hydrochloride
Country | Patent Number | Estimated Expiration |
---|---|---|
Australia | 7310401 | Start Trial |
Canada | 2413624 | Start Trial |
Japan | 2004501727 | Start Trial |
World Intellectual Property Organization (WIPO) | 0202182 | Start Trial |
Austria | 369891 | Start Trial |
European Patent Office | 1294439 | Start Trial |
Germany | 60129965 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.